Oscar Health (OSCR) Stock Price, News & Analysis

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" OSCR shares.
View OSCR analyst ratings or view top-rated stocks.

6 equities research analysts have issued 12 month price objectives for Oscar Health's shares. Their OSCR share price targets range from $7.50 to $20.00. On average, they expect the company's share price to reach $13.50 in the next twelve months. This suggests that the stock has a possible downside of 8.8%.
View analysts price targets for OSCR or view top-rated stocks among Wall Street analysts.

Oscar Health's stock was trading at $9.15 at the beginning of the year. Since then, OSCR stock has increased by 61.9% and is now trading at $14.81.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our OSCR earnings forecast.

Oscar Health will be holding an earnings conference call on Tuesday, May 7th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Oscar Health, Inc. (NYSE:OSCR) issued its earnings results on Wednesday, February, 7th. The company reported ($0.66) earnings per share for the quarter, beating analysts' consensus estimates of ($0.74) by $0.08. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.43 billion. Oscar Health had a negative trailing twelve-month return on equity of 29.99% and a negative net margin of 4.62%. Oscar Health's revenue was up 43.9% on a year-over-year basis. During the same quarter in the prior year, the company earned ($1.05) earnings per share.

ETFs with the largest weight of Oscar Health (NYSE:OSCR) stock in their portfolio include SPDR S&P Insurance ETF (KIE), SoFi Be Your Own Boss ETF (BYOB), SoFi Be Your Own Boss ETF (GIGE), Cambria Value and Momentum ETF (VAMO) and Harbor Health Care ETF (MEDI).iShares U.S. Insurance ETF (IAK).

Oscar Health issued an update on its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $8.3 billion-$8.4 billion, compared to the consensus revenue estimate of $6.8 billion.

207 employees have rated Oscar Health Chief Executive Officer Mario T. Schlosser on Glassdoor.com. Mario T. Schlosser has an approval rating of 95% among the company's employees. This puts Mario T. Schlosser in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 70.0% of employees surveyed would recommend working at Oscar Health to a friend.

Oscar Health (OSCR) raised $1 billion in an initial public offering (IPO) on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at a price of $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse acted as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

Oscar Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Gunderson Capital Management Inc. (0.11%), IMC Chicago LLC (0.00%) and Counterpoint Mutual Funds LLC (0.02%). Insiders that own company stock include Alessandrea C Quane, Alphabet Inc, Dennis Weaver, Joshua Kushner, Mario Schlosser, Meghan V Joyce, Ranmali Bopitiya, Richard Scott Blackley, Sid Sankaran, Thrive Partners Vii Growth Gp, and Victoria Baltrus.
View institutional ownership trends.

Shares of OSCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.